What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
His primary areas of study are Internal medicine, Cardiology, Myocardial infarction, Clopidogrel and Percutaneous coronary intervention.
Internal medicine is closely attributed to Surgery in his study.
His Surgery research includes elements of Platelet aggregation inhibitor and Risk factor.
His Cardiology study combines topics from a wide range of disciplines, such as Odds ratio and Pharmacotherapy.
Gilles Montalescot focuses mostly in the field of Clopidogrel, narrowing it down to topics relating to Anesthesia and, in certain cases, Placebo, Platelet activation and ST elevation.
The concepts of his Prasugrel study are interwoven with issues in Ticagrelor and Thienopyridine.
His most cited work include:
- Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes (4926 citations)
- 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. (3099 citations)
- Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events (2298 citations)
What are the main themes of his work throughout his whole career to date?
Gilles Montalescot mostly deals with Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI.
His Surgery research extends to Internal medicine, which is thematically connected.
His work on Coronary artery disease, Ticagrelor, ST segment and Angioplasty as part of general Cardiology study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His Myocardial infarction research integrates issues from Clinical endpoint, Randomized controlled trial and Hazard ratio.
In his research, Ticlopidine is intimately related to Platelet aggregation inhibitor, which falls under the overarching field of Percutaneous coronary intervention.
His research in Clopidogrel focuses on subjects like Anesthesia, which are connected to Platelet.
He most often published in these fields:
- Internal medicine (70.64%)
- Cardiology (58.33%)
- Myocardial infarction (39.62%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (70.64%)
- Cardiology (58.33%)
- Myocardial infarction (39.62%)
In recent papers he was focusing on the following fields of study:
Gilles Montalescot mainly focuses on Internal medicine, Cardiology, Myocardial infarction, Percutaneous coronary intervention and Conventional PCI.
His study in Internal medicine focuses on Stroke, Ticagrelor, Cardiogenic shock, Coronary artery disease and Hazard ratio.
He combines subjects such as Regimen, Loading dose and TIMI with his study of Ticagrelor.
His studies in Cardiology integrate themes in fields like Clinical endpoint and Shock.
His Myocardial infarction study is mostly concerned with Revascularization, ST segment, Mace, Acute coronary syndrome and Prasugrel.
His study explores the link between Percutaneous coronary intervention and topics such as Randomized controlled trial that cross with problems in Pharmacotherapy and Clinical trial.
Between 2017 and 2021, his most popular works were:
- 2018 ESC/EACTS Guidelines on myocardial revascularization. (2020 citations)
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). (1195 citations)
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS (93 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Cardiology
His main research concerns Internal medicine, Myocardial infarction, Cardiology, Percutaneous coronary intervention and Conventional PCI.
The Stroke, Aspirin, Confidence interval and Asymptomatic research he does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Alirocumab, therefore creating a link between diverse domains of science.
His Myocardial infarction research incorporates elements of Coronary artery disease, Heart failure and Hazard ratio.
In his works, Gilles Montalescot conducts interdisciplinary research on Cardiology and In patient.
His work carried out in the field of Percutaneous coronary intervention brings together such families of science as ST segment, Acute coronary syndrome and Revascularization.
Many of his research projects under Clopidogrel are closely connected to Action study with Action study, tying the diverse disciplines of science together.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
